Loading…
Reported covered position: Chief Counsel, House Energy & Commerce Committee (2015-2022); LD & Senior Policy Counsel, Rep. Rush (2012-2015); House Subcommittee on Commerce, Trade, & Consumer Protection (2009-2012)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to H.R. 946/S.1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D and Part B Pricing Reform; Issues related to home infusion under Medicare FFS; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ELECTION SYSTEMS & SOFTWARE, LLC via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to election security and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INFORMATION TECHNOLOGY INDUSTRY COUNCIL via TIBER CREEK GROUP
2025 · second_quarter · Q2
Source: Senate LDA
| Alnylam Pharmaceuticals, Inc. | 11 | 2023–2025 |
| NUSANO, INC. | 10 | 2023–2025 |
| SB ENERGY DEVCO (US), INC. | 10 | 2023–2025 |
| ELECTION SYSTEMS & SOFTWARE, LLC | 9 | 2023–2025 |
| MODIVCARE SOLUTIONS, LLC | 8 | 2022–2024 |
| UNIVERSITY OF ARIZONA FOUNDATION | 8 | 2022–2024 |
| DREAM CORPS | 6 | 2022–2023 |
| PREVENT OPIOID ABUSE | 4 | 2022–2023 |
| VIEW | 4 | 2023–2024 |
| GEORGIALINK PUBLIC AFFAIRS GROUP, LLC (O.B.O. DOUGHERTY COUNTY, GA) | 3 | 2025 |
| EVERYTOWN FOR GUN SAFETY ACTION FUND | 2 | 2025 |
| MCDERMOTT WILL & EMERY LLP (OBO ALNYLAM PHARMACEUTICALS) | 2 | 2022–2023 |
Remote Access Security Act
Client: INFORMATION TECHNOLOGY INDUSTRY COUNCIL · Firm: TIBER CREEK GROUP
Issues related to international trade including data flows, export controls, and U.S. - China relations; Issues related to H.R. 2683 - Remote Access Security Act.
Medicare Enrollment Protection Act of 2025
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to Medicare Enrollment and COBRA Continuation Coverage in H.R. 2744 - the Medicare Enrollment Protection Act.
Issues related to H.R. 946/S.1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Drug Rebate Program (MDRP); Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Drug Rebate Program (MDRP); Issues related to H.R. 946 - ORPHAN Cures Act.
Issues related to H.R. 946/S.1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Drug Rebate Program (MDRP); Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Saving Our Veterans Lives Act of 2025
Client: EVERYTOWN FOR GUN SAFETY ACTION FUND · Firm: TIBER CREEK GROUP
Issues related to S. 926 - Saving Our Veterans Lives Act of 2025.
American Relief Act, 2025
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Proposals impacting employer sponsored insurance, Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth in H.R.5378 - Lower Cost, More Transparency Act; H.R.10545 - American Relief Act of 2025 (PL 118-158).
American Relief Act, 2025
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to pharmacy and prescription drug pricing policy in H.R.5378 - Lower Cost, More Transparency Act, and H.R.10545 - American Relief Act of 2025 (PL 118-158).
Employer Reporting Improvement Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, employer sponsored insurance, prescription drugs, and telemedicine; H.R. 3801/S.3204 - Employer Reporting Improvement Act, issues related to employer reporting requirements; H.R. 5378 - Lower Cost, More Transparency Act.
Employer Reporting Improvement Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, employer sponsored insurance, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements; H.R. 5378 - Lower Cost, More Transparency Act.
Employer Reporting Improvement Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, employer sponsored insurance, prescription drugs, and telemedicine; H.R. 3801/S.3204 - Employer Reporting Improvement Act (PL 118-168); H.R. 5378 - Lower Cost, More Transparency Act.
Employer Reporting Improvement Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements; H.R. 5378 - Lower Cost, More Transparency Act; Issues related to pharmacy, prescription drugs, and health insurance in H.R. 4366 - the Consolidated Appropriations Act, 2024.
Consolidated Appropriations Act, 2024
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Proposals impacting Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act. Issues related to pharmacy, prescription drugs, and health insurance in the Consolidated Appropriations Act, 2024, HR 4366.
Consolidated Appropriations Act, 2024
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Proposals impacting employer sponsored insurance, Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act. Issues related to pharmacy, prescription drugs, and health insurance in the Consolidated Appropriations Act, 2024, HR 4366.
Consolidated Appropriations Act, 2024
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements; H.R. 5378 - Lower Cost, More Transparency Act; Issues related to pharmacy, prescription drugs, and health insurance in H.R. 4366 - the Consolidated Appropriations Act, 2024.
Lower Costs, More Transparency Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Proposals impacting employer sponsored insurance, Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act.
Lower Costs, More Transparency Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to pharmacy and prescription drug pricing policy in H.R.5378 - Lower Cost, More Transparency Act, and H.R.10545 - American Relief Act of 2025 (PL 118-158).
Lower Costs, More Transparency Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Proposals impacting employer sponsored insurance, Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth in H.R.5378 - Lower Cost, More Transparency Act; H.R.10545 - American Relief Act of 2025 (PL 118-158).
Lower Costs, More Transparency Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, employer sponsored insurance, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements; H.R. 5378 - Lower Cost, More Transparency Act.
Lower Costs, More Transparency Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, employer sponsored insurance, prescription drugs, and telemedicine; H.R. 3801/S.3204 - Employer Reporting Improvement Act, issues related to employer reporting requirements; H.R. 5378 - Lower Cost, More Transparency Act.
Lower Costs, More Transparency Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to pharmacy and prescription drug pricing policy; policies in H.R.5378 - Lower Cost, More Transparency Act.
Lower Costs, More Transparency Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Proposals impacting employer sponsored insurance, Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act. Issues related to pharmacy, prescription drugs, and health insurance in the Consolidated Appropriations Act, 2024, HR 4366.
Lower Costs, More Transparency Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Proposals impacting Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act. Issues related to pharmacy, prescription drugs, and health insurance in the Consolidated Appropriations Act, 2024, HR 4366.
Lower Costs, More Transparency Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Proposals impacting employer sponsored insurance, Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; policies in H.R.5378 - Lower Cost, More Transparency Act.
Lower Costs, More Transparency Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements; H.R. 5378 - Lower Cost, More Transparency Act; Issues related to pharmacy, prescription drugs, and health insurance in H.R. 4366 - the Consolidated Appropriations Act, 2024.
Lower Costs, More Transparency Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Proposals impacting Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act.
Lower Costs, More Transparency Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, employer sponsored insurance, prescription drugs, and telemedicine; H.R. 3801/S.3204 - Employer Reporting Improvement Act (PL 118-168); H.R. 5378 - Lower Cost, More Transparency Act.
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to the Medicaid Drug Rebate Program (MDRP); H.R.5539/S.3131 - ORPHAN Cures Act.
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to the Medicaid Drug Rebate Program (MDRP); H.R. 5539/S. 3131 - ORPHAN Cures Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to home infusion under Medicare FFS; H.R. 5547/S. 476 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
A Stronger Workforce for America Act
Client: INFORMATION TECHNOLOGY INDUSTRY COUNCIL · Firm: TIBER CREEK GROUP
Workforce development and training legislation; H.R. 6655 - A Stronger Workforce for America Act.
A Stronger Workforce for America Act
Client: INFORMATION TECHNOLOGY INDUSTRY COUNCIL · Firm: TIBER CREEK GROUP
Workforce development and training legislation; H.R.6655 - A Stronger Workforce for America Act.
A Stronger Workforce for America Act
Client: INFORMATION TECHNOLOGY INDUSTRY COUNCIL · Firm: TIBER CREEK GROUP
Workforce development and training legislation; Diversity and inclusion.; H.R. 6655 - A Stronger Workforce for America Act.
A Stronger Workforce for America Act
Client: INFORMATION TECHNOLOGY INDUSTRY COUNCIL · Firm: TIBER CREEK GROUP
Workforce development and training legislation; H.R. 6655 - A Stronger Workforce for America Act.
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to TRICARE in H.R. 8070 - Service Quality of Life Improvement and National Defense Authorization Act of Fiscal Year 2025.
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to TRICARE in H.R. 8070 - National Defense Authorization Act of Fiscal Year 2024.
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to TRICARE in H.R. 8070 - Service Quality of Life Improvement and National Defense Authorization Act of Fiscal Year 2025.
Energy and Water Development and Related Agencies Appropriations Act, 2025
Client: NUSANO, INC. · Firm: TIBER CREEK GROUP
Funding for medical radioisotopes; H.R.8997/S.4927 - Fiscal Year 2025 Energy and Water Development and Related Agencies Appropriations Act.
Energy and Water Development and Related Agencies Appropriations Act, 2025
Client: NUSANO, INC. · Firm: TIBER CREEK GROUP
Funding for medical radioisotopes; H.R.8997/S.4927 - Fiscal Year 2025 Energy and Water Development and Related Agencies Appropriations Act.
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to the Medicaid Drug Rebate Program (MDRP); H.R.5539/S.3131 - ORPHAN Cures Act.
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to the Medicaid Drug Rebate Program (MDRP); H.R. 5539/S. 3131 - ORPHAN Cures Act.
Employer Reporting Improvement Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, employer sponsored insurance, prescription drugs, and telemedicine; H.R. 3801/S.3204 - Employer Reporting Improvement Act, issues related to employer reporting requirements; H.R. 5378 - Lower Cost, More Transparency Act.
Employer Reporting Improvement Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, employer sponsored insurance, prescription drugs, and telemedicine; H.R. 3801/S.3204 - Employer Reporting Improvement Act (PL 118-168); H.R. 5378 - Lower Cost, More Transparency Act.
Artificial Intelligence Research, Innovation, and Accountability Act of 2024
Client: INFORMATION TECHNOLOGY INDUSTRY COUNCIL · Firm: TIBER CREEK GROUP
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; Provisions related to technology industry; Cybersecurity; S.3312 - Artificial Intelligence, Research, Innovation, and Accountability (AIRIA) Act of 2023.
Artificial Intelligence Research, Innovation, and Accountability Act of 2024
Client: INFORMATION TECHNOLOGY INDUSTRY COUNCIL · Firm: TIBER CREEK GROUP
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; provisions related to technology industry; Cybersecurity; S. 3312 - Artificial Intelligence, Research, Innovation, and Accountability (AIRIA) Act of 2023.
Artificial Intelligence Research, Innovation, and Accountability Act of 2024
Client: INFORMATION TECHNOLOGY INDUSTRY COUNCIL · Firm: TIBER CREEK GROUP
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; provisions related to technology industry; Cybersecurity; S. 3312 - Artificial Intelligence, Research, Innovation, and Accountability (AIRIA) Act of 2023.
Artificial Intelligence Research, Innovation, and Accountability Act of 2024
Client: INFORMATION TECHNOLOGY INDUSTRY COUNCIL · Firm: TIBER CREEK GROUP
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; Provisions related to technology industry; Cybersecurity; S.3312 - Artificial Intelligence, Research, Innovation, and Accountability (AIRIA) Act of 2023.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to home infusion under Medicare FFS; H.R. 5547/S. 476 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Energy and Water Development and Related Agencies Appropriations Act, 2025
Client: NUSANO, INC. · Firm: TIBER CREEK GROUP
Funding for medical radioisotopes; H.R.8997/S.4927 - Fiscal Year 2025 Energy and Water Development and Related Agencies Appropriations Act.
Energy and Water Development and Related Agencies Appropriations Act, 2025
Client: NUSANO, INC. · Firm: TIBER CREEK GROUP
Funding for medical radioisotopes; H.R.8997/S.4927 - Fiscal Year 2025 Energy and Water Development and Related Agencies Appropriations Act.
H.R. 1062/S. 524 - The Equal Act.
H.R. 1062 and S. 524 - The Equal Act.
H.R. 1062/S. 524 - The Equal Act.
H.R. 1062/S. 524 - The Equal Act.
Commonsense Reporting Act of 2023
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, prescription drugs, and telemedicine. Issues related to employer reporting requirements, HR 1264.
National Defense Authorization Act for Fiscal Year 2024
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to TRICARE; H.R.2670/S.2226 - Fiscal Year 2024 National Defense Authorization Act.
Employer Reporting Improvement Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements.
Employer Reporting Improvement Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements.
Employer Reporting Improvement Act
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements.
Lower Costs, More Transparency Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, prescription drugs, pharmacy policy, and employer sponsored insurance; H.R.5378 - Lower Cost, More Transparency Act.
Lower Costs, More Transparency Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Proposals impacting Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
National Defense Authorization Act for Fiscal Year 2024
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to TRICARE; H.R.2670/S.2226 - Fiscal Year 2024 National Defense Authorization Act.
Artificial Intelligence Research, Innovation, and Accountability Act of 2024
Client: INFORMATION TECHNOLOGY INDUSTRY COUNCIL · Firm: TIBER CREEK GROUP
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; provisions related to technology industry; Cybersecurity; S.3312 - Artificial Intelligence, Research, Innovation, and Accountability (AIRIA) Act of 2023.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; S.476 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; S.476 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
H.R. 1062/S. 524 - The Equal Act.
H.R. 1062 and S. 524 - The Equal Act.
H.R. 1062/S. 524 - The Equal Act.
H.R. 1062/S. 524 - The Equal Act.
Opioid Patients’ Right to Know Act of 2021
Client: PREVENT OPIOID ABUSE · Firm: TIBER CREEK GROUP
Issues related to opioid abuse prevention, H.R. 1185 - Opioid Patients Right to Know Act of 2021.
Opioid Patients’ Right to Know Act of 2021
Client: PREVENT OPIOID ABUSE · Firm: TIBER CREEK GROUP
Issues related to opioid abuse prevention, H.R. 1185 - Opioid Patients Right to Know Act of 2021.
Opioid Patients’ Right to Know Act of 2021
Client: PREVENT OPIOID ABUSE · Firm: TIBER CREEK GROUP
Issues related to opioid abuse prevention, H.R. 1185 - Opioid Patients Right to Know Act of 2021.
Opioid Patients’ Right to Know Act of 2021
Client: PREVENT OPIOID ABUSE · Firm: TIBER CREEK GROUP
Issues related to opioid abuse prevention, H.R. 1185 - Opioid Patients Right to Know Act of 2021.
Opioid Patients’ Right to Know Act of 2021
Client: PREVENT OPIOID ABUSE · Firm: TIBER CREEK GROUP
Issues related to opioid abuse prevention, H.R. 1185 - Opioid Patients Right to Know Act of 2021.
Opioid Patients’ Right to Know Act of 2021
Client: PREVENT OPIOID ABUSE · Firm: TIBER CREEK GROUP
Issues related to opioid abuse prevention, H.R. 1185 - Opioid Patients Right to Know Act of 2021.
Opioid Patients’ Right to Know Act of 2021
Client: PREVENT OPIOID ABUSE · Firm: TIBER CREEK GROUP
Issues related to opioid abuse prevention, H.R. 1185 - Opioid Patients Right to Know Act of 2021.
Opioid Patients’ Right to Know Act of 2021
Client: PREVENT OPIOID ABUSE · Firm: TIBER CREEK GROUP
Issues related to opioid abuse prevention, H.R. 1185 - Opioid Patients Right to Know Act of 2021.
S.79 and HR 1693, the EQUAL Act of 2021, issues related to energy permitting, issues related to implementation of the environmental provisions of PL 117-169, the Inflation Reduction Act.
S.79 and HR 1693, the EQUAL Act of 2021, issues related to energy permitting, issues related to implementation of the environmental provisions of PL 117-169, the Inflation Reduction Act.
H.R. 1693 and S. 79 - The Equal Act of 2021
FedRAMP Authorization Act
Client: INFORMATION TECHNOLOGY INDUSTRY COUNCIL · Firm: TIBER CREEK GROUP
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; provisions related to technology industry; Cybersecurity; H.R. 21 - Federal Risk and Authorization Management Program (FedRAMP) Authorization Act of 2021; S.3600 - Strengthening American Cybersecurity Act of 2022; S. 2902/H.R. 6497 - the Federal Information Security Modernization Act of 2022.
Issues related to expanding Medicaid, including H.R. 5376 - the Build Back Better Act; Issues related to prior authorization for transportation services; Issues related to medical transportation in H.R. 8295 - the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023.
Inflation Reduction Act of 2022
Client: EOS ENERGY ENTERPRISES LLC (FKA EOS ENERGY STORAGE LLC) · Firm: TIBER CREEK GROUP
Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); H.R. 5376 - Build Back Better Act; Issues related to domestic content and advanced manufacturing; American Rescue Plan Act of 2021 (PL 117-2); H.R. 848 - Growing Renewable Energy and Efficiency Now (GREEN) Act of 2021; S. 627 - Energy Storage Tax Incentive and Deployment Act; S.1298 - Clean Energy for America Act.
Inflation Reduction Act of 2022
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues impacting insurance coverage, prescription drugs, the federal COVID response; Mental health care; Employer sponsored insurance; Issues related to the H.R. 5376 - Build Back Better Act, budget reconciliation legislation; Issues related to S. 4293 - the Pharmacy Benefit Manager Transparency Act of 2022.
H.R. 5376 - Build Back Better Act, Subtitle J; Inflation Reduction Act of 2022 (PL 117-169), Subtitle B - Prescription Drug Pricing Reform; Issues relating to Part D pricing reform; Issues relating to Medicare Part D and Part B Pricing Reform.
Inflation Reduction Act of 2022
Client: EOS ENERGY ENTERPRISES LLC (FKA EOS ENERGY STORAGE LLC) · Firm: TIBER CREEK GROUP
Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); H.R. 5376 - Build Back Better Act; Issues related to domestic content and advanced manufacturing; American Rescue Plan Act of 2021 (PL 117-2); H.R. 848 - Growing Renewable Energy and Efficiency Now (GREEN) Act of 2021; S. 627 - Energy Storage Tax Incentive and Deployment Act; S.1298 - Clean Energy for America Act; Issues related to Notice of Intent No. DE-FOA-0002677 Notice of Intent to Issue Funding Opportunity Announcement No. DE-FOA-0002678
Issues related to artificial intelligence; Issues related to the implementation and funding of the Chips & Science Act (PL 117-167); Issues related to quantum computing.
Issues related to broadband deployment; Spectrum Policy; USF Reform; Artificial intelligence; Acquisition; 5G; Supply chain; Provisions related to technology industry; Cybersecurity.
Issues related to FY'26 appropriations; Issues related to government reform and IT modernization.
Issues related to international trade including data flows, export controls, and U.S. - China relations; Issues related to H.R. 2683 - Remote Access Security Act.
Issues related to workforce development and training legislation.
Privacy; Data security; Encryption; Law enforcement access to data; Platform reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SB ENERGY DEVCO (US), INC. via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGIALINK PUBLIC AFFAIRS GROUP, LLC (O.B.O. DOUGHERTY COUNTY, GA) via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to promoting domestic production of radioisotopes.
Issues related to promoting domestic production of radioisotopes and its impact on cancer care.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to insurance coverage, ACA market reforms, and telemedicine in the One Big Beautiful Bill Act (PL 119-21).
Issues related to Medicare Enrollment and COBRA Continuation Coverage in H.R. 2744 - the Medicare Enrollment Protection Act.
Issues related to health savings accounts in the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERYTOWN FOR GUN SAFETY ACTION FUND via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to gun safety.
Issues related to gun safety and funding for ATF.
Issues related to gun safety and tax incentives for secure storage; Issues related to tax policy and firearms in the One Big Beautiful Bill Act (PL 119-21).
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to pharmacy, Medicare Part D, and prescription drug pricing policy.
Issues related to proposals impacting employer sponsored insurance; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth; Issues related to an extension of enhanced premium tax credits and health insurance affordability. Issues related to tax and health coverage changes in the One Big Beautiful Bill Act (PL 119-21).
Pharmacy issues related to TRICARE.
EOS ENERGY ENTERPRISES LLC (FKA EOS ENERGY STORAGE LLC) via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
ASTRAZENECA via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Drug Rebate Program (MDRP); Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to H.R. 946/S.1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TPI COMPOSITES, INC. via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues pertaining to the wind industry, tax, and trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELECTION SYSTEMS & SOFTWARE, LLC via TIBER CREEK GROUP
2025 · first_quarter · Q1
Issues related to election security and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2025 · first_quarter · Q1
Issues related to promoting domestic production of radioisotopes.
Issues related to promoting domestic production of radioisotopes and its impact on cancer care.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2025 · first_quarter · Q1
Issues related to insurance coverage, ACA market reforms, and telemedicine.
Issues related to Medicare Enrollment and COBRA Continuation Coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2025 · first_quarter · Q1
Issues related to pharmacy, Medicare Part D, and prescription drug pricing policy.
Issues related to proposals impacting employer sponsored insurance; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth; Issues related to an extension of enhanced premium tax credits and health insurance affordability.
Pharmacy issues related to TRICARE.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INFORMATION TECHNOLOGY INDUSTRY COUNCIL via TIBER CREEK GROUP
2025 · first_quarter · Q1
Issues related to workforce development and training legislation.
Privacy; Data security; Encryption; Law enforcement access to data; Platform reform.
Issues related to artificial intelligence; Issues related to the implementation and funding of the Chips & Science Act (PL 117-167); Issues related to quantum computing.
GEORGIALINK PUBLIC AFFAIRS GROUP, LLC (O.B.O. DOUGHERTY COUNTY, GA) via TIBER CREEK GROUP
2025 · first_quarter · Q1
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Filing targets: SENATE
EOS ENERGY ENTERPRISES LLC (FKA EOS ENERGY STORAGE LLC) via TIBER CREEK GROUP
2025 · first_quarter · Q1
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
ASTRAZENECA via TIBER CREEK GROUP
2025 · first_quarter · Q1
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Drug Rebate Program (MDRP); Issues related to H.R. 946 - ORPHAN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2025 · first_quarter · Q1
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D and Part B Pricing Reform; Issues related to home infusion under Medicare FFS; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SB ENERGY DEVCO (US), INC. via TIBER CREEK GROUP
2025 · first_quarter · Q1
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169) and Inflation Reduction Act tax credits.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
TPI COMPOSITES, INC. via TIBER CREEK GROUP
2025 · first_quarter · Q1
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues pertaining to the wind industry, tax, and trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGIALINK PUBLIC AFFAIRS GROUP, LLC (O.B.O. DOUGHERTY COUNTY, GA) via TIBER CREEK GROUP
2025 · first_quarter · RR
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
EVERYTOWN FOR GUN SAFETY ACTION FUND via TIBER CREEK GROUP
2025 · first_quarter · RR
Issues related to gun safety.
Issues related to gun safety.
Issues related to gun safety.
ELECTION SYSTEMS & SOFTWARE, LLC via TIBER CREEK GROUP
2024 · fourth_quarter · Q4
Issues related to election security and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INFORMATION TECHNOLOGY INDUSTRY COUNCIL via TIBER CREEK GROUP
2024 · fourth_quarter · Q4
Artificial Intelligence; Internet of things.
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; Provisions related to technology industry; Cybersecurity; S.3312 - Artificial Intelligence, Research, Innovation, and Accountability (AIRIA) Act of 2023.
Privacy; Data breach notification; Data security; Electronic Communications Privacy Act (PL 99-508) reform; Internet of Things; Encryption; Law enforcement access to data; Platform reform.
SB ENERGY DEVCO (US), INC. via TIBER CREEK GROUP
2024 · fourth_quarter · Q4
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
TPI COMPOSITES, INC. via TIBER CREEK GROUP
2024 · fourth_quarter · Q4
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues pertaining to the wind industry, tax, and trade.
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2024 · fourth_quarter · Q4
Funding for medical radioisotopes; H.R.8997/S.4927 - Fiscal Year 2025 Energy and Water Development and Related Agencies Appropriations Act.
Issues related to promoting domestic production of radioisotopes and its impact on cancer care.
Issues related to promoting domestic production of radioisotopes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2024 · fourth_quarter · Q4
Issues related to insurance coverage, employer sponsored insurance, prescription drugs, and telemedicine; H.R. 3801/S.3204 - Employer Reporting Improvement Act (PL 118-168); H.R. 5378 - Lower Cost, More Transparency Act.
Issues related to Medicare Part D open enrollment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2024 · fourth_quarter · Q4
Pharmacy issues related to TRICARE in H.R. 8070 - Service Quality of Life Improvement and National Defense Authorization Act of Fiscal Year 2025.
Proposals impacting employer sponsored insurance, Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth in H.R.5378 - Lower Cost, More Transparency Act; H.R.10545 - American Relief Act of 2025 (PL 118-158).
Issues related to pharmacy and prescription drug pricing policy in H.R.5378 - Lower Cost, More Transparency Act, and H.R.10545 - American Relief Act of 2025 (PL 118-158).
EOS ENERGY ENTERPRISES LLC (FKA EOS ENERGY STORAGE LLC) via TIBER CREEK GROUP
2024 · fourth_quarter · Q4
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ASTRAZENECA via TIBER CREEK GROUP
2024 · fourth_quarter · Q4
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to the Medicaid Drug Rebate Program (MDRP); H.R. 5539/S. 3131 - ORPHAN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2024 · fourth_quarter · Q4
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to home infusion under Medicare FFS; H.R. 5547/S. 476 - Maintaining Investments in New Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SB ENERGY DEVCO (US), INC. via TIBER CREEK GROUP
2024 · third_quarter · Q3
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
EOS ENERGY ENTERPRISES LLC (FKA EOS ENERGY STORAGE LLC) via TIBER CREEK GROUP
2024 · third_quarter · Q3
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Filing targets: Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ELECTION SYSTEMS & SOFTWARE, LLC via TIBER CREEK GROUP
2024 · third_quarter · Q3
Issues related to election security and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA via TIBER CREEK GROUP
2024 · third_quarter · Q3
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to the Medicaid Drug Rebate Program (MDRP); H.R.5539/S.3131 - ORPHAN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2024 · third_quarter · Q3
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INFORMATION TECHNOLOGY INDUSTRY COUNCIL via TIBER CREEK GROUP
2024 · third_quarter · Q3
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; Provisions related to technology industry; Cybersecurity; S.3312 - Artificial Intelligence, Research, Innovation, and Accountability (AIRIA) Act of 2023.
Privacy; Data breach notification; Data security; Electronic Communications Privacy Act (PL 99-508) reform; Internet of Things; Encryption; Law enforcement access to data; Platform reform.
Artificial Intelligence; Internet of things.
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2024 · third_quarter · Q3
Proposals impacting employer sponsored insurance, Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; policies in H.R.5378 - Lower Cost, More Transparency Act.
Pharmacy issues related to TRICARE in H.R. 8070 - Service Quality of Life Improvement and National Defense Authorization Act of Fiscal Year 2025.
Issues related to pharmacy and prescription drug pricing policy; policies in H.R.5378 - Lower Cost, More Transparency Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2024 · third_quarter · Q3
Issues related to promoting domestic production of radioisotopes and its impact on cancer care.
Issues related to promoting domestic production of radioisotopes.
Funding for medical radioisotopes; H.R.8997/S.4927 - Fiscal Year 2025 Energy and Water Development and Related Agencies Appropriations Act.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2024 · third_quarter · Q3
Issues related to insurance coverage, employer sponsored insurance, prescription drugs, and telemedicine; H.R. 3801/S.3204 - Employer Reporting Improvement Act, issues related to employer reporting requirements; H.R. 5378 - Lower Cost, More Transparency Act.
Issues related to Medicare Part D open enrollment; Issues related to Medicare enrollment and COBRA continuation coverage (PL 99-272).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TPI COMPOSITES, INC. via TIBER CREEK GROUP
2024 · third_quarter · Q3
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues pertaining to the wind industry, tax, and trade.
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2024 · second_quarter · Q2
Pharmacy issues related to TRICARE in H.R. 8070 - National Defense Authorization Act of Fiscal Year 2024.
Proposals impacting Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act.
Proposals impacting employer sponsored insurance, Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EOS ENERGY ENTERPRISES LLC (FKA EOS ENERGY STORAGE LLC) via TIBER CREEK GROUP
2024 · second_quarter · Q2
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Filing targets: Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ASTRAZENECA via TIBER CREEK GROUP
2024 · second_quarter · Q2
Issues related to sustainability of health care sector.
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to the Medicaid Drug Rebate Program (MDRP).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2024 · second_quarter · Q2
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2024 · second_quarter · Q2
Issues related to promoting domestic production of radioisotopes.
Funding for medical radioisotopes; Fiscal Year 2025 Energy and Water Development and Related Agencies Appropriations Act.
Issues related to promoting domestic production of radioisotopes and its impact on cancer care.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2024 · second_quarter · Q2
Issues related to Medicare Part D open enrollment; Issues related to Medicare enrollment and COBRA continuation coverage (PL 99-272). Issues related to regulation of insurance agents in the 2025 Medicare Advantage Policy and Technical rule.
Issues related to insurance coverage, employer sponsored insurance, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements; H.R. 5378 - Lower Cost, More Transparency Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SB ENERGY DEVCO (US), INC. via TIBER CREEK GROUP
2024 · second_quarter · Q2
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ELECTION SYSTEMS & SOFTWARE, LLC via TIBER CREEK GROUP
2024 · second_quarter · Q2
Issues related to election security and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF ARIZONA FOUNDATION via TIBER CREEK GROUP
2024 · second_quarter · 2T
Issues pertaining to Dept of Education regulations.
Issues pertaining to Labor, Health and Human Services, Education appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
TPI COMPOSITES, INC. via TIBER CREEK GROUP
2024 · second_quarter · Q2
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act (PL 117-169).
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act (PL 117-169).
Issues pertaining to the wind industry, tax, and trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INFORMATION TECHNOLOGY INDUSTRY COUNCIL via TIBER CREEK GROUP
2024 · second_quarter · Q2
Artificial Intelligence; Internet of things.
Privacy; Data breach notification; Data security; Electronic Communications Privacy Act (PL 99-508) reform; Internet of Things; Encryption; Law enforcement access to data; Platform reform.
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; provisions related to technology industry; Cybersecurity; S. 3312 - Artificial Intelligence, Research, Innovation, and Accountability (AIRIA) Act of 2023.
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2024 · first_quarter · Q1
Proposals impacting Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act. Issues related to pharmacy, prescription drugs, and health insurance in the Consolidated Appropriations Act, 2024, HR 4366.
Proposals impacting employer sponsored insurance, Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act. Issues related to pharmacy, prescription drugs, and health insurance in the Consolidated Appropriations Act, 2024, HR 4366.
2024 · first_quarter · Q1
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Investment Tax Credit (ITC).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SB ENERGY DEVCO (US), INC. via TIBER CREEK GROUP
2024 · first_quarter · Q1
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
TPI COMPOSITES, INC. via TIBER CREEK GROUP
2024 · first_quarter · Q1
Issues pertaining to the wind industry, tax, and trade.
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act (PL 117-169).
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INFORMATION TECHNOLOGY INDUSTRY COUNCIL via TIBER CREEK GROUP
2024 · first_quarter · Q1
Privacy; Data breach notification; Data security; Electronic Communications Privacy Act (PL 99-508) reform; Internet of Things; Encryption; Law enforcement access to data; Platform reform.
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; provisions related to technology industry; Cybersecurity; S. 3312 - Artificial Intelligence, Research, Innovation, and Accountability (AIRIA) Act of 2023.
Workforce development and training legislation; Diversity and inclusion.; H.R. 6655 - A Stronger Workforce for America Act.
NUSANO, INC. via TIBER CREEK GROUP
2024 · first_quarter · Q1
Issues related to promoting domestic production of radioisotopes and its impact on cancer care.
Issues related to promoting domestic production of radioisotopes.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2024 · first_quarter · Q1
Issues related to insurance coverage, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements; H.R. 5378 - Lower Cost, More Transparency Act; Issues related to pharmacy, prescription drugs, and health insurance in H.R. 4366 - the Consolidated Appropriations Act, 2024.
Issues related to Medicare marketing rules; Issues related to Medicare Part D open enrollment; Issues related to Medicare enrollment and COBRA continuation coverage (PL 99-272).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MODIVCARE SOLUTIONS, LLC via TIBER CREEK GROUP
2024 · first_quarter · Q1
Issues related to access to non-emergency medical transportation services; Issues related to home and community-based care in the Ensuring Access to Medicaid Services (CMS 2442-P) proposed rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELECTION SYSTEMS & SOFTWARE, LLC via TIBER CREEK GROUP
2024 · first_quarter · Q1
Issues related to election security and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF ARIZONA FOUNDATION via TIBER CREEK GROUP
2024 · first_quarter · Q1
Issues pertaining to Labor, Health and Human Services, Education appropriations.
Issues pertaining to Dept of Education regulations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
EOS ENERGY ENTERPRISES LLC (FKA EOS ENERGY STORAGE LLC) via TIBER CREEK GROUP
2024 · first_quarter · Q1
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Filing targets: Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ASTRAZENECA via TIBER CREEK GROUP
2024 · first_quarter · Q1
Issues related to sustainability of health care sector.
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to the Medicaid Drug Rebate Program (MDRP).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2024 · first_quarter · Q1
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Proposals impacting Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act.
Issues related to insurance coverage, prescription drugs, pharmacy policy, and employer sponsored insurance; H.R.5378 - Lower Cost, More Transparency Act.
Pharmacy issues related to TRICARE; H.R.2670/S.2226 - Fiscal Year 2024 National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EOS ENERGY ENTERPRISES LLC (FKA EOS ENERGY STORAGE LLC) via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
ASTRAZENECA via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform.
Issues related to sustainability of health care sector.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Issues related to promoting domestic production of radioisotopes.
Issues related to promoting domestic production of radioisotopes and its impact on cancer care.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
INFORMATION TECHNOLOGY INDUSTRY COUNCIL via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Workforce development and training legislation; Diversity and inclusion.
Artificial Intelligence; Internet of things.
Privacy; Data breach notification; Data security; Electronic Communications Privacy Act (PL 99-508) reform; Internet of Things; Encryption; Law enforcement access to data; Platform reform.
ELECTION SYSTEMS & SOFTWARE, LLC via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Issues related to election security and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DREAM CORPS via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Energy permitting reform.
Funding for clean energy programs.
H.R. 1062/S. 524 - The Equal Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Issues related to Medicare marketing rules; Issues related to Medicare Part D open enrollment; Issues related to Medicare enrollment and COBRA continuation coverage (PL 99-272).
Issues related to insurance coverage, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MODIVCARE SOLUTIONS, LLC via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Issues related to access to non-emergency medical transportation services; Issues related to home and community-based care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF ARIZONA FOUNDATION via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Issues pertaining to Labor, Health and Human Services, Education appropriations.
Issues pertaining to Dept of Education regulations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2023 · fourth_quarter · Q4
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Investment Tax Credit (ITC).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TPI COMPOSITES, INC. via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Issues pertaining to the wind industry, tax, and trade.
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act (PL 117-169).
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SB ENERGY DEVCO (US), INC. via TIBER CREEK GROUP
2023 · fourth_quarter · Q4
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2023 · third_quarter · Q3
Pharmacy issues related to TRICARE.
Proposals impacting Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related pharmacy and prescription drug pricing policy.
Issues related to insurance coverage, prescription drugs, pharmacy policy, telemedicine, and employer sponsored insurance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA via TIBER CREEK GROUP
2023 · third_quarter · Q3
Issues related to sustainability of health care sector.
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2023 · third_quarter · Q3
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2023 · third_quarter · Q3
Issues related to promoting domestic production of radioisotopes.
Issues related to promoting domestic production of radioisotopes and its impact on cancer care.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2023 · third_quarter · Q3
Issues related to Medicare marketing rules; Issues related to Medicare Part D open enrollment; Issues related to Medicare enrollment and COBRA continuation coverage (PL 99-272).
Issues related to insurance coverage, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MODIVCARE SOLUTIONS, LLC via TIBER CREEK GROUP
2023 · third_quarter · Q3
Issues related to access to non-emergency medical transportation services; Issues related to home and community-based care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Q3
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Investment Tax Credit (ITC).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TPI COMPOSITES, INC. via TIBER CREEK GROUP
2023 · third_quarter · Q3
Issues pertaining to the wind industry, tax, and trade; United States-Mexico-Canada Agreement Implementation Act (PL 116-113); Monitoring of US sanctions policy with respect to Russian invasion of Ukraine.
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act (PL 117-169).
Issues pertaining to the wind industry, tax, and trade; Implementation of the Inflation Reduction Act (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELECTION SYSTEMS & SOFTWARE, LLC via TIBER CREEK GROUP
2023 · third_quarter · Q3
Issues related to election security and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DREAM CORPS via TIBER CREEK GROUP
2023 · third_quarter · Q3
H.R. 1062/S. 524 - The Equal Act.
Funding for clean energy programs.
Energy permitting reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SB ENERGY DEVCO (US), INC. via TIBER CREEK GROUP
2023 · third_quarter · Q3
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
INFORMATION TECHNOLOGY INDUSTRY COUNCIL via TIBER CREEK GROUP
2023 · third_quarter · Q3
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; provisions related to technology industry; Cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
EOS ENERGY ENTERPRISES LLC (FKA EOS ENERGY STORAGE LLC) via TIBER CREEK GROUP
2023 · third_quarter · Q3
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169). Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Issues related to the implementation of Inflation Reduction Act of 2022 (PL 117-169); Issues related to energy storage; Issues related to the Section 48 Investment Tax Credit (ITC); Issues related to domestic content and advanced manufacturing; Issues related to DOE LPO program.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
UNIVERSITY OF ARIZONA FOUNDATION via TIBER CREEK GROUP
2023 · third_quarter · Q3
Issues pertaining to Labor, Health and Human Services, Education appropriations.
Issues pertaining to Dept of Education regulations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
ELECTION SYSTEMS & SOFTWARE, LLC via TIBER CREEK GROUP
2023 · second_quarter · Q2
Issues related to election security and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DREAM CORPS via TIBER CREEK GROUP
2023 · second_quarter · Q2
Funding for clean energy programs.
H.R. 1062/S. 524 - The Equal Act.
Energy permitting reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Q2
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Investment Tax Credit (ITC).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to S. 926 - Saving Our Veterans Lives Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Issues related to broadband deployment; Spectrum Policy; USF Reform; Artificial intelligence; Acquisition; 5G; Supply chain; Provisions related to technology industry; Cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Workforce development and training legislation; H.R. 6655 - A Stronger Workforce for America Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Workforce development and training legislation; H.R.6655 - A Stronger Workforce for America Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Workforce development and training legislation; H.R. 6655 - A Stronger Workforce for America Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Pharmacy issues related to TRICARE; National Defense Authorization Act of Fiscal Year 2024 (PL 118-31).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Artificial Intelligence; Internet of things.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to international trade including data flows, export controls, and U.S.-China relations.
Broadband deployment; WiFi issues; Spectrum Policy; USF Reform; Internet regulation; Internet of Things; Artificial intelligence; Acquisition; 5G; Supply chain; provisions related to technology industry; Cybersecurity; S.3312 - Artificial Intelligence, Research, Innovation, and Accountability (AIRIA) Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)